|
Investigation of metformin (MET) in patients with castration resistant prostate cancer (CRPC) in combination with enzalutamide (ENZ) vs. ENZ alone: A randomized, open label, phase 2 trial. SAKK 08/14—IMPROVE. |
|
Christian Alexander Rothermundt |
Consulting or Advisory Role - Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Novartis (Inst); Pfizer (Inst); PharmaMar (Inst) |
Research Funding - Astellas Pharma (Inst) |
|
|
Consulting or Advisory Role - Amgen (Inst); Astellas Oncology (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Janssen (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst) |
Research Funding - Janssen (Inst) |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Astellas Oncology; Bayer; Sanofi/Aventis |
|
|
Travel, Accommodations, Expenses - Abbvie; Celgene; SERVIER |
|
|
Consulting or Advisory Role - Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Lilly (Inst); Merck Serono (Inst); MSD Oncology (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst) |
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst) |
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Lilly; Merck Sharp & Dohme; Roche Pharma AG |
|
|
No Relationships to Disclose |
|
|
Stock and Other Ownership Interests - Amgen; Karyopharm Therapeutics; Teva |
Travel, Accommodations, Expenses - Amgen |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Astellas Oncology; BMS Brazil; Eisai; Genzyme; Novartis; Roche; Sanofi |
Travel, Accommodations, Expenses - Astellas Oncology; BMS Brazil; Eisai; Genzyme; Novartis; Roche; Sanofi |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Honoraria - Abbvie; Celgene; Lilly; Merck; Sanofi |
Travel, Accommodations, Expenses - Amgen; Bayer; BMS Brazil; Boehringer Ingelheim; Lilly |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Active Biotech (Inst); Active Biotech (Inst); Advanced Accelerator Applications (Inst); Advanced Accelerator Applications (Inst); Astellas Pharma (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); CureVac (Inst); Curevac (Inst); Ferring (Inst); Ferring (Inst); Innocrin Pharma (Inst); Janssen (Inst); MaxiVax ; Novartis (Inst); Orion (Inst); Roche (Inst); Sanofi; Sanofi (Inst) |
Patents, Royalties, Other Intellectual Property - Method for biomarker (WO 3752009138392 A1) |
Travel, Accommodations, Expenses - Diverse Companies |
Other Relationship - Astellas Medivation; ESSA; Nektar; ProteoMediX |